Oppenheimer Asset Management
ITCI icon

Oppenheimer Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Oppenheimer Asset Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40,434
Closed -$3.38M – 1208
2024
Q4 		$3.38M Buy
40,434
+1,584
+4% +$130K 0.04% 413
2024
Q3 		$2.84M Buy
38,850
+3,358
+9% +$252K 0.03% 452
2024
Q2 		$2.43M Buy
35,492
+6,382
+22% +$443K 0.03% 474
2024
Q1 		$2.01M Sell
29,110
-5,688
-16% -$391K 0.03% 481
2023
Q4 		$2.49M Buy
34,798
+374
+1% +$21.5K 0.03% 451
2023
Q3 		$1.79M Buy
34,424
+2,969
+9% +$173K 0.03% 526
2023
Q2 		$1.99M Sell
31,455
-1,998
-6% -$125K 0.03% 510
2023
Q1 		$1.81M Buy
33,453
+4,160
+14% +$201K 0.03% 524
2022
Q4 		$1.55M Sell
29,293
-1,173
-4% -$58.8K 0.03% 549
2022
Q3 		$1.42M Buy
30,466
+11,877
+64% +$620K 0.03% 553
2022
Q2 		$1.06M Sell
18,589
-5,180
-22% -$294K 0.02% 657
2022
Q1 		$1.46M Buy
23,769
+5,088
+27% +$264K 0.02% 636
2021
Q4 		$978K Buy
18,681
+2,651
+17% +$111K 0.01% 785
2021
Q3 		$598K Buy
+16,030
New +$557K 0.01% 891

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pentwater Capital Management
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HBK Investments
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Davidson Kempner Capital Management
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UBS O'Connor
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Oppenheimer Asset Management's ITCI Position: Q1 2025 in Review

Oppenheimer Asset Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 40,434 shares — an estimated $3.38M sold.

Oppenheimer Asset Management first reported a position in ITCI in Q3 2021 and held it in 14 quarters. The position peaked at $3.38M in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Oppenheimer Asset Management reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Oppenheimer Asset Management sold 40,434 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $3.38M.
  • Oppenheimer Asset Management first reported a position in Intra-Cellular Therapies Inc. in Q3 2021 and held it in 14 quarters.
  • Oppenheimer Asset Management's Intra-Cellular Therapies Inc. position peaked at $3.38M in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Oppenheimer Asset Management's 13F filing for Q1 2025, filed 23 Apr 2025.